Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Indications:
GLIPITA 50MG is indicated for the treatment of type 2 diabetes mellitus, especially when diet and exercise alone are insufficient to control blood glucose levels.
Pharmacology:
GLIPITA contains glipizide, a sulfonylurea class drug that stimulates insulin secretion from pancreatic beta cells, thereby lowering blood glucose levels.
Dosage:
Typical starting dose is 5mg once or twice daily, which may be increased gradually to a maximum of 40mg daily based on patient response. Dose should be individualized by the physician.
Administration:
Oral administration, preferably 30 minutes before meals. Swallow tablets whole with water.
Interaction:
May interact with other hypoglycemic agents, beta-blockers, corticosteroids, and alcohol. These interactions can alter blood sugar control.
Contraindications:
-
Type 1 diabetes mellitus
-
Diabetic ketoacidosis
-
Hypersensitivity to sulfonylureas
Side Effects:
-
Hypoglycemia
-
Nausea, vomiting
-
Dizziness
-
Allergic skin reactions
-
Weight gain
Pregnancy & Lactation:
Use only if clearly needed and prescribed by a doctor. Insufficient data on safety during pregnancy and lactation.
Precautions & Warnings:
-
Monitor blood glucose regularly
-
Use with caution in patients with liver or kidney impairment
-
Avoid alcohol as it may cause severe hypoglycemia
-
Adjust dose during illness or stress
Therapeutic Class:
Oral hypoglycemic agent – Sulfonylurea
Storage Conditions:
Store in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep out of reach of children.
 400MG.jpg)
.jpg)
 100 IU.jpg)
 60 ML.jpg)
 350ML.jpg)
 10025 100 MG 25 MG.jpg)
 30PCS.jpg)
 350ML.jpg)
.jpg)
 15050160.jpg)
 100 IU.jpg)
 20025 20025.jpg)
Change Language